Charles River (NYSE: CRL) officer to sell 2,039 shares after option exercise

Rhea-AI Filing Summary

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) is the issuer of common stock that an officer, Shannon M. Parisotto, has notified for potential resale under Rule 144. The notice lists 2,039 common securities, with UBS Financial Services Inc. acting as broker, and references the NYSE and a date of 08/19/2026.

The filing also lists prior dispositions of CRL common securities by Shannon M. Parisotto during the past three months: 5,046 units on 08/05/2026 and 3,714 units on 08/11/2026, each with stated transaction values. A figure of 47,738,872 common securities is shown for CRL, providing context for the issuer’s total amount of this class.

Key Figures

Planned common securities under Rule 144: 2039 Issuer common securities figure: 47738872 Past 3 months sale 1 – units: 5046 +3 more

6 metrics

Planned common securities under Rule 144 2039 Number of CRL common securities identified for resale with reference date 08/19/2026

Issuer common securities figure 47738872 Figure shown for total CRL common securities in the securities information section

Past 3 months sale 1 – units 5046 CRL common securities listed as sold on 08/05/2026 by Shannon M. Parisotto

Past 3 months sale 1 – value 1327098.00 Value associated with 5,046 CRL common securities sold on 08/05/2026

Past 3 months sale 2 – units 3714 CRL common securities listed as sold on 08/11/2026 by Shannon M. Parisotto

Past 3 months sale 2 – value 1038657.24 Value associated with 3,714 CRL common securities sold on 08/11/2026

Key Terms

Rule 144, attorney-in-fact, Exercise of Stock Options

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

attorney-in-fact regulatory

"Signature | /s/ UBS Financial Services Inc, as attorney-in-fact for Shannon Parisotto"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

Exercise of Stock Options financial

"Common | 08/19/2026 | Exercise of Stock Options | Issuer"

FAQ

What does the Form 144 filing disclose for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)?

The Form 144 notice discloses that an officer, Shannon M. Parisotto, intends to resell 2,039 CRL common securities under Rule 144, using UBS Financial Services Inc. as broker, with a reference date of 08/19/2026 and listing on the NYSE.

How many CRL common securities has Shannon M. Parisotto sold in the last three months?

The filing lists sales of 5,046 CRL common securities on 08/05/2026 and 3,714 on 08/11/2026. These transactions are reported with stated values of 1,327,098.00 and 1,038,657.24, respectively, for CRL common securities.

What is the size of the planned Rule 144 sale relative to CRL’s total common securities?

The notice identifies 2,039 CRL common securities in the planned Rule 144 sale, while also showing a figure of 47,738,872 CRL common securities for the issuer. This provides context that the planned amount is small relative to that total figure.

Who is the person selling CRL securities under this Form 144 notice?

The notice is for sales on behalf of Shannon M. Parisotto, described as an officer of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. The signature section shows UBS Financial Services Inc. signing as attorney-in-fact for Shannon M. Parisotto.

What is the role of UBS Financial Services Inc. in the CRL Form 144 filing?

UBS Financial Services Inc. is listed as the broker for the CRL common securities and signs the notice as attorney-in-fact for Shannon M. Parisotto. The securities information line associates UBS Financial Services Inc. with the common securities referenced in the filing.

What transaction method is associated with the CRL securities in this Form 144?

The Form 144 indicates that the CRL common securities are related to an Exercise of Stock Options, with the transaction characterized as involving the Issuer and a cash-related entry on 08/19/2026. This links the planned sale to option exercise activity.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/19/2026 - 04:17 PM Accepted by SEC EDGAR 08/19/2026 - 04:15 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001952784
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
SEC File Number	001-15943
Address of Issuer	251 BALLARDVALE ST WILMINGTON MASSACHUSETTS 01887
Phone	781-222-6000
Name of Person for Whose Account the Securities are To Be Sold	Parisotto Shannon M
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc 11 Madison Ave 4th Floor New York NY 10010	2039	599710.68	47738872	08/19/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/19/2026	Exercise of Stock Options	Issuer			2039	08/19/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Shannon M. Parisotto 251 BALLARDVALE ST WILMINGTON MA 01887	Common	08/05/2026	5046	1327098.00
Shannon M. Parisotto 251 BALLARDVALE ST WILMINGTON MA 01887	Common	08/11/2026	3714	1038657.24

144: Remarks and Signature

Remarks
Date of Notice	08/19/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/04/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ UBS Financial Services Inc, as attorney-in-fact for Shannon Parisotto
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)